Mizuho Financial Group, Inc. (MFG)
After hours:
| Previous close | 4.2700 |
| Open | 4.3100 |
| Bid | 4.2200 x 2900 |
| Ask | 4.3500 x 1300 |
| Day's range | 4.2701 - 4.3000 |
| 52-week range | 3.0900 - 4.5000 |
| Volume | |
| Avg. volume | 695,667 |
| Market cap | 54.365B |
| Beta (5Y monthly) | 0.45 |
| PE ratio (TTM) | 12.26 |
| EPS (TTM) | 0.3500 |
| Earnings date | 31 Jul 2024 |
| Forward dividend & yield | 0.14 (3.22%) |
| Ex-dividend date | 27 Mar 2024 |
| 1y target est | 5.70 |
BloombergMizuho Seeks to Back More Strategic Deals By Japan’s Mid-Caps
(Bloomberg) -- A growing number of Japan’s mid-cap companies are considering buyouts and other strategic options, according to Mizuho Financial Group Inc., which is seeking to increase lending and advisory services to the sector.Most Read from BloombergDemocrats Weigh Mid-July Vote to Formally Tap Biden as NomineePowerful Hurricane Beryl Aims at Jamaica After Grenada StrikeTrump Immunity Ruling Means Any Trial Before Election Unlikely‘Upflation’ Is the New Retail Trend Driving Up Prices for US C
Insider MonkeyDid Mizuho Financial Group, Inc. (MFG) Outperform Expectations in the Last Quarter?
We recently compiled a list of the 10 Best Bank Penny Stocks to Buy Now. In this article, we are going to take a look at where Mizuho Financial Group, Inc. (NYSE:MFG) stands against the other bank penny stocks. The US banking sector in 2024 faces various challenges and opportunities. Although the industry has recovered […]
GlobeNewswireMizuho Americas Hires Steven Valiquette as Managing Director and Senior Equity Research Analyst to Cover Health Care Technology & Distribution
NEW YORK, June 11, 2024 (GLOBE NEWSWIRE) -- Mizuho Americas today announced the hiring of Steven Valiquette as Managing Director and Senior Equity Research Analyst, covering Health Care Technology & Distribution. Based in New York, Valiquette reports to the Head of Americas Equity Research, Bill Featherston. Valiquette has more than 25 years of experience covering the Health Care sector and has been ranked in the top five in Health Care Technology & Distribution in the Institutional Investor’s A
